Pharmafile Logo

Beacon consulting

Beacon Consulting is a specialist pharmaceutical consultancy. We help our clients solve difficult commercial problems and maximise the opportunities for their brands by providing actionable, data driven analysis. We focus on using NHS secondary data sources such as Hospital Episode Statistics (HES), QoF and GP prescribing data to add insight to challenges in: estimating market sizes, modelling patient flows through the health care system, describing variation in treatment practice, patient and physician segmentation, profiling and targeting, forecasting and examining healthcare resource usage and costs.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Foxacre, Parkland Grove, Farnham, Surrey, GU9 9HA, United Kingdom
+44 (0)1252 758988

 Latest Content from PMHub 

What does it mean to be an agile organisation

We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.

Battling breast cancer with precision medicine (Part 2)

Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Corporate event food. How to get it right

Food affects our mood. When we are hungry, we are more likely to be irritable and unhappy. On the other hand, being full makes us happy and relaxed. But, with...

How patient insights were brought to life with graphic novel outputs

Research Partnership's client was developing a novel therapy for the treatment of a rare disease in which patients suffer acute symptomatic attacks; the main burden of disease is not just...

Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports

Living with Ankylosing Spondylitis (AS) & nr-AxSpA are reports based on quantitative studies conducted online in the 5EU and US. The AS 5EU report comprises of interviews with 385 patients...

Insight full – our short survey

There is still time to shift the balance in our survey. Let us know how satisfied you are with yours?

Battling breast cancer with precision medicine (Part 1)

Laura Holmes Haddad is a breast cancer survivor. She made the incredibly brave decision to participate in a PARP inhibitor precision medicine trial. Here, the author and precision medicine advocate...

Nucleus Global starts ‘Summer Hours’ initiative

Nucleus Global staff can now finish at 2pm on Fridays throughout July and August

Rewarding long service at Porterhouse Medical Group

The Porterhouse Medical Group provides insight-driven medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions that can have a significant and measurable...

The role of brain health in treating MS

Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health,...